## **Core Concept**
The question assesses knowledge of antiviral drugs, specifically those effective against hepatitis viruses. Hepatitis viruses are classified into several types, including hepatitis B (HBV) and hepatitis C (HCV), each requiring different treatment approaches. Antiviral drugs targeting these viruses can be highly specific.

## **Why the Correct Answer is Right**
Ribavirin is a nucleoside analogue with broad-spectrum antiviral activity, including against hepatitis C virus (HCV) when used in combination with other drugs like interferon or direct-acting antivirals (DAAs). It works by mechanisms that include inhibiting viral RNA synthesis. Therefore, Ribavirin is indeed active against hepatitis, specifically HCV.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include drugs not primarily used for hepatitis treatment.
- **Option B:** Similarly, without specifics, we can infer that any drug listed here would not have significant or recognized activity against hepatitis viruses.
- **Option C:** Again, lacking details, we assume this option does not effectively target hepatitis viruses.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that treatment for hepatitis, especially chronic hepatitis B and C, often involves direct-acting antivirals (DAAs) for HCV, and nucleos(t)ide analogues for HBV. Ribavirin, though used in the past more frequently, now typically serves as part of combination therapy.

## **Correct Answer:** . Ribavirin